Co-Authors
This is a "connection" page, showing publications co-authored by CLIONA ROONEY and DAVID QUACH.
Connection Strength
2.540
-
Rejection resistant CD30.CAR-modified Epstein-Barr virus-specific T?cells as an off-the-shelf platform for CD30+ lymphoma. Mol Ther Oncol. 2024 Jun 20; 32(2):200814.
Score: 0.964
-
Banking on virus-specific T cells to fulfill the need for?off-the-shelf cell therapies. Blood. 2023 02 23; 141(8):877-885.
Score: 0.885
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240.
Score: 0.691